Applied DNA Sciences Inc (APDN): Slide # 26 is informative. The annualize...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Applied DNA Sciences Inc (APDN)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	183
Boards Moderated	0
Alias Born	09/10/2016

Re: None

Thursday, 12/07/2017 4:05:48 PM

Thursday, December 07, 2017 4:05:48 PM

Slide # 26 is informative. The annualized recurring revenue growth rate
percentage change is accelerating quite dramatically recently. While still
below the profitability threshold of approximately 12-15 million dollars,
what was 2 million in Q1, is now about 7 million in Q4. Better than 300%
revenue rate increase. Tho Puny in absolute numbers, the growth rate suggests profitability next year.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent APDN News

Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/04/2024 10:18:33 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/12/2024 09:25:36 PM
Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/12/2024 09:09:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:05:22 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/08/2024 09:01:31 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/01/2024 09:05:28 PM
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:24:06 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/10/2024 10:16:03 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:00:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:05:23 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/07/2023 09:01:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 09:05:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 10:09:34 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/07/2023 10:02:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 08:05:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:05:45 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:01:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 08:02:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 09:04:44 PM

More APDN News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow